GlassScriptPhysician profile
Jason M Edwards
NPI 1568721454
$5,399.28
in general payments reported to CMS, 2019-2025
11 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $177 · 2021: $3,890 · 2022: $565 · 2023: $135 · 2024: $157 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $4,164.85 | 2019-2025 | Flexitouch Plus, Nimbl |
| Koya Medical, INC. | $503.28 | 2022 | |
| Gt Medical Technologies, INC | $210.66 | 2023-2025 | Gammatile, Gammatile |
| Astrazeneca Pharmaceuticals LP | $127.34 | 2019 | |
| Medtronic USA, INC. | $122.12 | 2019 | |
| Siemens Medical Solutions USA, INC. | $105.25 | 2023 | Truebeam |
| Visionrt, INC. | $53.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $49.85 | 2024 | |
| Novocure INC. | $22.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.40 | 2020 | |
| Genzyme Corporation | $19.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.